Angioedema during therapy with recombinant tissue plasminogen activator.
Francis
C W
CW
Department of Medicine, University of Rochester, School of Medicine and Dentistry, New York.
Brenner
B
B
Leddy
J P
JP
Marder
V J
VJ
D000799:Angioedema / Q000139:chemically induced* / Q000276:immunology; D003167:Complement Activation / Q000502:physiology; D005260:Female; D006801:Humans; D008875:Middle Aged; D011994:Recombinant Proteins / Q000009:adverse effects; D010959:Tissue Plasminogen Activator / Q000009:adverse effects*
D011994:Recombinant Proteins; D010959:Tissue Plasminogen Activator